Schroder Investment Management Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Sell |
129,103
-8,118
| -6% | -$254K | ﹤0.01% | 806 |
|
|
2025
Q1 | $4.7M | Sell |
137,221
-39,453
| -22% | -$1.35M | ﹤0.01% | 765 |
|
|
2024
Q4 | $6.81M | Hold |
176,674
| – | – | 0.01% | 718 |
|
|
2024
Q3 | $6.83M | Buy |
176,674
+85,174
| +93% | +$3.29M | 0.01% | 737 |
|
|
2024
Q2 | $3.57M | Hold |
91,500
| – | – | ﹤0.01% | 839 |
|
|
2024
Q1 | $3.94M | Hold |
91,500
| – | – | ﹤0.01% | 819 |
|
|
2023
Q4 | $4.21M | Buy |
+91,500
| New | +$4.21M | 0.01% | 799 |
|